← Back to Search

Procedure

1 for Ultrasound

N/A
Waitlist Available
Led By Kevin M. Kelly, M.D.
Research Sponsored by SonoCine, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year after sonocine screening
Awards & highlights

Study Summary

The purpose of this study is to determine whether addition of automated whole breast ultrasound to the usual screening mammography in a population of asymptomatic women with mammographically dense breasts will result in a significantly greater number of breast cancers discovered than would be found by mammography alone.

Eligible Conditions
  • Ultrasound
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year after sonocine screening
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year after sonocine screening for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Numbers of breast cancers detected

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Adjunct screening with sonocine

Find a Location

Who is running the clinical trial?

SonoCine, Inc.Lead Sponsor
Kevin M. Kelly, M.D.Principal InvestigatorSonoCine, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~208 spots leftby May 2025